Twist Bioscience Corporation (TWST) Financial Statements

Executive TeamFinancials
SegmentsShareholders

Twist Bioscience financial statements at a glance

Twist Bioscience reported revenue of $376.57 million for fiscal year 2025 (ended September 30, 2025), up 20.3% from fiscal year 2024. Net income was -$77.67 million, a net margin of 20.6% loss, and diluted earnings per share were -$1.30.

At the end of fiscal year 2025 it had total assets of $641.86 million, total liabilities of $168.90 million and shareholders' equity of $472.96 million, with cash and short-term investments of $232.43 million and total debt of $75.57 million.

Its operations brought in -$47.63 million of cash; capital spending was $28.00 million, leaving free cash flow of -$75.63 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended September 30, 2025.

TWST logo

Twist Bioscience Corporation

TWSTUnited States
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
376.57M
Prev Year: 312.97M
YoY: +20.3%
Operating Revenue
376.57M
Prev Year: 312.97M
YoY: +20.3%
Total Unusual Items Excluding Goodwill
48.85M
Prev Year: -44.93M
YoY: +208.7%
Total Unusual Items
48.85M
Prev Year: -44.93M
YoY: +208.7%
Normalized EBITDA
-160.25M
Prev Year: -131.78M
YoY: -21.6%
Tax Rate for Calcs
0.21
Prev Year: 0
Tax Effect of Unusual Items
10.26M
Prev Year: 0
Gain on Sale of Business
48.85M
Prev Year: 0
Cost of Revenue
185.57M
Prev Year: 179.63M
YoY: +3.3%
Gross Profit
191.00M
Prev Year: 133.35M
YoY: +43.2%
Operating Expense
327.26M
Prev Year: 309.25M
YoY: +5.8%
Selling General and Administrative
246.98M
Prev Year: 218.40M
YoY: +13.1%
Research and Development
80.28M
Prev Year: 90.85M
YoY: -11.6%
Operating Income
-136.26M
Prev Year: -175.90M
YoY: +22.5%
Net Non Operating Interest Income Expense
11.36M
Prev Year: 15.31M
YoY: -25.8%
Non-operating Interest Income
11.36M
Prev Year: 15.34M
YoY: -25.9%
Other Income Expense
47.94M
Prev Year: -47.58M
YoY: +200.8%
Special Income Charges
48.85M
Prev Year: -44.93M
YoY: +208.7%
Other Non-operating Income (expense)
-903.0K
Prev Year: -2.65M
YoY: +65.9%
Pre-tax Income
-76.95M
Prev Year: -208.17M
YoY: +63.0%
Provision for Income Taxes
719.0K
Prev Year: 560.0K
YoY: +28.4%
Net Income Common Stockholders
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Net Income
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Net Income Including Non-Controlling Interests
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Net Income from Continuing Operations
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Diluted NI Available to Com Stockholders
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Basic EPS
-1.3
Prev Year: -3.6
YoY: +63.9%
Diluted EPS
-1.3
Prev Year: -3.6
YoY: +63.9%
Weighted Average Shares (basic)
59.81M
Prev Year: 58.02M
YoY: +3.1%
Weighted Average Shares (diluted)
59.81M
Prev Year: 58.02M
YoY: +3.1%
Total Operating Income as Reported
-136.26M
Prev Year: -220.83M
YoY: +38.3%
Total Expenses
512.83M
Prev Year: 488.88M
YoY: +4.9%
Net Income from Continuing and Discontinued Operation
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Normalized Income
-116.26M
Prev Year: -163.80M
YoY: +29.0%
Interest Income
11.36M
Prev Year: 15.34M
YoY: -25.9%
Net Interest Income
11.36M
Prev Year: 15.31M
YoY: -25.8%
Interest Expense
-
Prev Year: 29.0K
EBIT
-136.26M
Prev Year: -208.14M
YoY: +34.5%
EBITDA
-111.41M
Prev Year: -176.71M
YoY: +37.0%
Reconciled Cost of Revenue
185.57M
Prev Year: 179.63M
YoY: +3.3%
Reconciled Depreciation
24.85M
Prev Year: 31.43M
YoY: -20.9%
Net Income from Continuing Operation Net Minority Interest
-77.67M
Prev Year: -208.73M
YoY: +62.8%
Values in USD

Twist Bioscience key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$376.6M$313.0M$245.1M$203.6M$132.3M
Gross profit$191.0M$133.3M$89.7M$84.2M$51.7M
Operating income-$136.3M-$175.9M-$206.9M-$249.0M-$153.3M
Net income-$77.7M-$208.7M-$204.6M-$217.9M-$152.1M
Diluted EPS-$1.30-$3.60-$3.60-$4.04-$3.15
Total assets$641.9M$614.3M$776.4M$961.4M$702.1M
Total liabilities$168.9M$141.6M$153.0M$172.0M$121.3M
Shareholders' equity$473.0M$472.7M$623.4M$789.4M$580.8M
Cash and short-term investments$232.4M$276.4M$336.4M$505.0M$477.9M
Total debt$75.6M$85.0M$94.1M$94.9M$62.9M
Operating cash flow-$47.6M-$64.1M-$142.5M-$124.4M-$112.2M
Capital spending$28.0M$5.1M$27.8M$101.9M$27.1M
Free cash flow-$75.6M-$69.2M-$170.3M-$226.2M-$139.3M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2016.

Questions and answers

What was Twist Bioscience's revenue in fiscal year 2025?

$376.57 million, up 20.3% from $312.97 million in fiscal year 2024.

How much profit does Twist Bioscience make?

Twist Bioscience reported net income of -$77.67 million for fiscal year 2025 (20.6% of revenue); operating income was -$136.26 million.

How much cash and debt does Twist Bioscience have?

At the end of fiscal year 2025: cash and short-term investments of $232.43 million and total debt of $75.57 million.

What is Twist Bioscience's free cash flow?

-$75.63 million in fiscal year 2025 (operating cash flow of -$47.63 million minus capital spending of $28.00 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube